Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-29 Exercise | 2022-03-30 9:54 pm | N/A 2027-02-13 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 24,606 | $0 | 97,990 (Direct) | View |
| 2022-03-29 Exercise | 2022-03-30 9:54 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 24,606 | $1.97 | 97,990 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:06 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:57 pm | N/A 2027-10-17 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 73,384 | $0 | 103,512 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:57 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 14,780 | $1.97 | 103,512 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:57 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 4,650 | $2.46 | 103,512 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:57 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 53,954 | $2.95 | 103,512 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-26 6:04 pm | N/A 2031-07-19 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2021-04-22 7:15 pm | N/A 2027-02-13 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 0 | $0 | 128,118 (Direct) | View |